Ngā hua rapu - Maryvonne Hourmant
- E whakaatu ana i te 1 - 20 hua o te 32
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
A simple clinical tool to inform the decision-making process to refer elderly incident dialysis patients for kidney transplant evaluation mā Emmanuelle Dusseux, Laetitia Albano, C. Fafin, Maryvonne Hourmant, Olivier Guérin, Cécile Couchoud, Olivier Moranne
I whakaputaina 2015Artigo -
4
-
5
-
6
A RANDOMIZED MULTICENTER TRIAL COMPARING LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 MONOCLONAL ANTIBODY WITH RABBIT ANTITHYMOCYTE GLOBULIN AS INDUCTION TREATMENT IN FIRST KIDNEY TRANS... mā Maryvonne Hourmant, J Bedrossian, Dominique Durand, Yvon Lebranchu, E. Renoult, Pierre Caudrelier, Renaud Buffet, Jean-Paul Soulillou
I whakaputaina 1996Artigo -
7
-
8
Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of... mā Jean-Paul Soulillou, Diego Cantarovich, Brigitte Le Mauff, Magali Giral, Nelly Robillard, Maryvonne Hourmant, M. Hirn, Yannick Jacques
I whakaputaina 1990Artigo -
9
Benefits of kidney transplantation for a national cohort of patients aged 70 years and older starting renal replacement therapy mā Camille Legeai, Roland Andrianasolo, Olivier Moranne, Renaud Snanoudj, Maryvonne Hourmant, Marc Bauwens, Joaquim Soares, Christian Jacquelinet, Cécile Couchoud, Marie‐Alice Macher
I whakaputaina 2018Artigo -
10
Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation mā Stéphanie Le Bas‐Bernardet, Maryvonne Hourmant, Nathalie Valentin, Catherine Paitier, Magali Giral‐Classe, Sylvie Curry, Gilles Folléa, Jean‐Paul Soulillou, Jean‐Denis Bignon
I whakaputaina 2003Artigo -
11
Recurrence and Graft Loss after Kidney Transplantation for Henoch–Schönlein Purpura Nephritis mā Nada Kanaan, Georges Mourad, Éric Thervet, Patrick Peeters, Maryvonne Hourmant, Yves Vanrenterghem, Martine De Meyer, Michel Mourad, Céline Maréchal, Éric Goffin, Yves Pirson
I whakaputaina 2011Artigo -
12
Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome mā Fádi Fakhouri, Mathieu Jablonski, J. Lepercq, Jacques Blouin, Alexandra Benachi, Maryvonne Hourmant, Yves Pirson, Antoine Dürrbach, Jean‐Pierre Grünfeld, Bertrand Knebelmann, Véronique Frémeaux‐Bacchi
I whakaputaina 2008Artigo -
13
Acute graft pyelonephritis and long-term kidney allograft outcome mā Magali Giral, Giovani Pascuariello, Georges Karam, Maryvonne Hourmant, Diego Cantarovich, Jacques Dantal, Gilles Blancho, Stéphanie Coupel, Régis Josien, Pascal Daguin, Sandra Méchineau, Jean Paul Soulillou
I whakaputaina 2002Artigo -
14
Ten-year survival of second kidney transplants: Impact of immunologic factors and renal function at 12months mā Stéphanie Coupel, Magali Giral‐Classe, Georges Karam, Jean‐François Morcet, Jacques Dantal, Diego Cantarovich, Gilles Blancho, Jean‐Denis Bignon, Pascal Daguin, Jean‐Paul Soulillou, Maryvonne Hourmant
I whakaputaina 2003Artigo -
15
Multivariate analysis of donor risk factors for graft survival in kidney transplantation mā Fabienne Pessione, Sophie Cohen, D. Durand, Maryvonne Hourmant, Mich le Kessler, Christophe Legendre, Georges Mourad, Christian No l, Marie-No lle Peraldi, Claire Pouteil‐Noble, Philippe Tuppin, C Hiesse
I whakaputaina 2003Artigo -
16
A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response mā Christophe Masset, Clarisse Kerleau, Claire F. Garandeau, Simon Ville, Diego Cantarovich, Maryvonne Hourmant, Delphine Kervella, Aurélie Houzet, Cécile Guillot-Gueguen, Irène Guihard, Magali Giral, Jacques Dantal, Gilles Blancho
I whakaputaina 2021Carta -
17
Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance mā Joëlle Guitard, Anne‐Laure Hebral, Fádi Fakhouri, Dominique Joly, Éric Daugas, Joseph Rivalan, Vincent Guigonis, Françis Ducret, Claire Presne, Yves Pirson, Maryvonne Hourmant, Jean-Claude Glachant, Benoı̂t Vendrely, Olivier Moranne, Stanislas Faguer, Dominique Chauveau
I whakaputaina 2014Artigo -
18
Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial mā Fádi Fakhouri, Maryvonne Hourmant, Josep M. Campistol, Spero R. Cataland, Mario Espinosa, A. Osama Gaber, Jan Menne, Enrico Minetti, François Provôt, Éric Rondeau, Piero Ruggenenti, Laurent Weekers, Masayo Ogawa, Camille L. Bedrosian, Christophe Legendre
I whakaputaina 2016Artigo -
19
Frequency and Clinical Implications of Development of Donor-Specific and Non–Donor-Specific HLA Antibodies after Kidney Transplantation mā Maryvonne Hourmant, Anne Cesbron‐Gautier, Paul I. Terasaki, Kazuo Mizutani, Philippe Moreau, AureCombining Acute Accentlie Meurette, Jacques Dantal, Magali Giral, Gilles Blancho, Diego Cantarovich, Georges Karam, Gilles Folléa, Jean‐Paul Soulillou, Jean‐Denis Bignon
I whakaputaina 2005Artigo -
20
Acute respiratory failure in kidney transplant recipients: a multicenter study mā Emmanuel Canet, David Osman, Jérôme Lambert, Christophe Guitton, Anne‐Elisabeth Heng, Laurent Argaud, Kada Klouche, Georges Mourad, Christophe Legendre, Jean‐François Timsit, Eric Rondeau, Maryvonne Hourmant, Antoine Dürrbach, Denis Glotz, Bertrand Souweine, Benoı̂t Schlemmer, Élie Azoulay
I whakaputaina 2011Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Transplantation
Immunology
Kidney transplantation
Cohort
Disease
Kidney disease
Renal function
Antibody
Dialysis
Gastroenterology
Surgery
Intensive care medicine
Kidney
Urology
Environmental health
Physics
Population
Cohort study
Nephrology
Antigen
Atypical hemolytic uremic syndrome
Complement system
Confidence interval
Creatinine
Eculizumab
Incidence (geometry)
Optics
Pediatrics